LivingGLP1
Study S002434

Assessment of Retinal-Angio Findings in Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies

Registration

Registration
NCT07602348
Acronym
ARIADNE
Study type
OBSERVATIONAL
Status
ACTIVE_NOT_RECRUITING
Enrollment
40
Start
2024-03-01
Primary completion
2026-01-30
Lead sponsor
University of Athens
Conditions
Diabetic Retinopathy; GLP-1; SGLT 2 Inhibitors; Endothelial Dysfunction; Microvascular Circulation; Retinal Vascular Diseases
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Changes in Ocular Parameters [Changes from baseline to 12-month follow-up.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.